Vanguard Capital Wealth Advisors Eloxx Pharmaceuticals, Inc. Transaction History

Vanguard Capital Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$0.15 - $7.2 $4,335 - $208,080	-28,900 Reduced 18.54%	127,000 $22,000
Q2 2022 Aug 04, 2022	SELL	$0.24 - $0.58 $720 - $1,739	-3,000 Reduced 1.89%	155,900 $41,000
Q4 2021 Feb 02, 2022	SELL	$0.62 - $1.61 $172,980 - $449,190	-279,000 Reduced 63.71%	158,900 $111,000
Q3 2021 Nov 01, 2021	BUY	$1.22 - $2.0 $381,738 - $625,800	312,900 Added 250.32%	437,900 $457,000
Q2 2021 Jul 28, 2021	BUY	$1.35 - $3.36 $168,750 - $420,000	125,000 New	125,000 $248,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.